Heart Center Research, Llc
Huntsville, Alabama 35801-4317
12 studies enrolling now · 77 studies all time
What they study most
AKI, AV Block, Acute Coronary Syndrome, Acute Coronary Syndrome (ACS), Acute Coronary Syndromes, Acute Kidney Injury (AKI), Acute Myocardial Infarction, Anemia, Angina Pectoris, Aortic Stenosis, Atherosclerosis, Atherosclerotic Cardiovascular Disease
Studies at this site
- OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events — Recruiting now
- Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention — Recruiting now
- Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure — Recruiting now
- Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease — Recruiting now
- A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis — Recruiting now
- An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230) — Recruiting now
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity — Recruiting now
- Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study — Recruiting now
- Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity — Recruiting now
- A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis — Recruiting now
- Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts — Recruiting now
- A Study of DII235 in Adults With Elevated Lipoprotein(a) — Running, not enrolling
- SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System — Completed
- Selatogrel Outcome Study in Suspected Acute Myocardial Infarction — Enrolling by invitation
- Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events — Running, not enrolling
- Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
- Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD — Running, not enrolling
- ASCEND CSP IDE Study — Running, not enrolling
- AMPLATZER PFO Occluder Post Approval Study — Running, not enrolling
- Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial — Running, not enrolling
- Amplatzer Amulet LAAO vs. NOAC — Running, not enrolling
- A Proof of Concept and Dose-finding Study of XXB750 in Patients With Heart Failure — Stopped early
- SyncAV Post-Market Trial — Running, not enrolling
- Abbott Atrial Fibrillation Post Approval Study — Running, not enrolling
- A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD) — Completed
- EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction — Running, not enrolling
- The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker — Completed
- Retrospective Observational Study of Patients Who Have Undergone Coronary Artery Bypass Graft (CABG) and/or Cardiac Valve Surgery — Running, not enrolling
- Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction — Completed
- SPYRAL PIVOTAL - SPYRAL HTN-OFF MED Study — Completed
- AMPLATZER™ Amulet™ LAA Occluder Trial — Completed
- FUnctional diagnoSIs of corONary Stenosis (FUSION) — Completed
- EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction) — Completed
- Study to Evaluate the Efficacy of ASP1128 (MA-0217) in Subjects at Risk for Acute Kidney Injury (AKI) Following Coronary Artery Bypass Graft (CABG) and/or Valve Surgery — Completed
- LUX-Dx Insertable Cardiac Monitor Remote Programming and Performance Study — Completed
- Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP — Completed
- Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator — Completed
- Physiologic Pacing Registry — Completed
- Global Prevalence of ATTR-CM in Participants With HFpEF — Stopped early
- Effect of RBT-1 on Preconditioning Response Biomarkers in Subjects Undergoing CABG and/or Cardiac Valve Surgery — Completed
- Multiple Cardiac Sensors for the Management of Heart Failure — Completed
- S-ICD® System Post Approval Study — Completed
- CONVERGE - Epi/Endo Ablation For Treatment of Persistent Atrial Fibrillation(AF) — Completed
- MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint Pacing — Stopped early
- CONVERGE CAP Study-For The Treatment Of Symptomatic Persistent or Long-standing Persistent AF — Withdrawn before enrolling
- INGEVITY+ Active Fixation Pace/Sense Lead Clinical Study — Completed
- EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved) — Completed
- XIENCE 28 USA Study — Completed
- Strategic Management to Optimize Response To Cardiac Resynchronization Therapy — Completed
- INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure — Completed